Table 1.
Serum | Number of subjects | Vimentin-positive | P value* |
---|---|---|---|
Pancreatic cancer | 36 | 16 (44.4%) | |
Chronic pancreatitis | 18 | 1 (5.6%) | P = 0.003 |
Healthy Individuals | 15 | 0 (0%) | P = 0.001 |
Serum | Number of subjects | Vimentin-positive | P value* |
---|---|---|---|
Pancreatic cancer | 36 | 16 (44.4%) | |
Chronic pancreatitis | 18 | 1 (5.6%) | P = 0.003 |
Healthy Individuals | 15 | 0 (0%) | P = 0.001 |